跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe
Approved
STANDARD
VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe
Merck Sharp & Dohme (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
eeb44f5a57a45c94
Company
Merck Sharp & Dohme (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
eeb44f5a57a45c94
Product Name
VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe
Artg Id
350791
Artg Name
VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe
Sponsor
Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path
/organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date
2022-01-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/c3771030ebaeaa1d9814f7c8be2c9fc8.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a9af53e07d311d60bd38f9028bbe602d.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
eeb44f5a57a45c94
Type
Standard
Back to TGA Approvals